Orphanet: Pesquisa simples
x

Pesquisar um ensaio clínico

* (*) campo(s) de preenchimento obrigatório

264 Resultado(s)

Ordenados por

Ensaio em fase de recrutamento = Ensaio em fase de recrutamento; Ensaio a decorrer = Ensaio a decorrer; Financiado por um membro do IRDiRC =

Ensaio (s) clínico (s) nacional (is)

ALEMANHA

Baden-Württemberg
ULM

Ensaio em fase de recrutamentoEnsaio a decorrerEMAA: Efficacy and Safety of Eltrombopag in Patients with Acquired Moderate Aplastic Anemia who are treated with Ciclosporin A (Phase II/III) - DE
DRK Baden-Württemberg/ Hessen
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm

ALEMANHA

Baden-Württemberg
HEIDELBERG

Ensaio a decorrerMPN-SG 01-09 (MPN Pomalidomide): Multicenter Phase II Study with Pomalidomide in patients with Myeloproliferative Neoplasms in fibrotic Stage
Nationales Centrum für Tumorerkrankungen (NCT)
Nationales Centrum für Tumorerkrankungen (CCC) Heidelberg

ALEMANHA

Baden-Württemberg
ULM

ALEMANHA

Hamburg
HAMBURG

Ensaio em fase de recrutamentoEnsaio a decorrerRuxolitinib versus allogeneic stem cell transplantation for patients with myelofibrosis according to donor availability: A prospective phase II trial (MMM 02 study) - DE
UKE - Universitätsklinikum Hamburg-Eppendorf
Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation

ALEMANHA

Nordrhein-Westfalen
AACHEN

ALEMANHA

Nordrhein-Westfalen
MINDEN

Ensaio a decorrerJHTB(a): A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms - DE
Johannes Wesling Klinikum Minden
Klinik für Hämatologie, Onkologie und Palliativmedizin

AUSTRIA

SALZBURG
SALZBURG

Ensaio em fase de recrutamentoEnsaio a decorrerAn Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis - AT
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
Universitätsklinik für Innere Medizin III

AUSTRIA

WIEN
WIEN

Ensaio a decorrerA Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

AUSTRIA

WIEN
WIEN

Ensaio em fase de recrutamentoEnsaio a decorrerA Phase 2, Open-Label Study of Parsaclisib in Participants With Autoimmune Hemolytic Anemia - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

AUSTRIA

WIEN
WIEN

Ensaio em fase de recrutamentoEnsaio a decorrerA Phase 3, Open-Label, Multicenter Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS) - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Pädiatrische Nephrologie und Gastroenterologie

ESPANHA

Andalucía
CÓRDOBA

ESPANHA

Cataluña
ESPLUGUES DE LLOBREGAT

Ensaio a decorrerA Phase 3, Open-Label, Multicenter Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS) - ES
Hospital Sant Joan de Déu Barcelona
Servicio de nefrología pediátrica y trasplante renal

ESPANHA

Comunidad Valenciana
VALENCIA

ESPANHA

Madrid
ADDRESS: NOT PROVIDED - ES

ESTADOS UNIDOS

New York
NEW YORK

ESTADOS UNIDOS

New York
NEW YORK

ESTADOS UNIDOS

Ohio
CINCINNATI

Ensaio em fase de recrutamentoEnsaio a decorrerFinanciado por um membro do IRDiRCQuercetin in Children With Fanconi Anemia; a Pilot Study (Phase 1/2) - US
Cincinnati Children's Hospital Medical Center
Department of Pediatry

FRANCA

ILE-DE-FRANCE
PARIS

FRANCA

ILE-DE-FRANCE
PARIS

ITALIA

LOMBARDIA
MILANO

Ensaio em fase de recrutamentoEnsaio a decorrerAn open-label, multi-center clinical trial of eculizumab in pediatric patients with atypical hemolytic-uremic syndrome (aHUS) (Phase II) - IT
IRCCS Ca' Granda - Ospedale Maggiore Policlinico - Clinica Pediatrica De Marchi
Centro per la Cura e lo Studio della Sindrome Emolitico Uremica (Center for HUS Control)

PAISES BAIXOS

Gelderland
NIJMEGEN

PAISES BAIXOS

Gelderland
NIJMEGEN

PAISES BAIXOS

Noord-Holland
AMSTERDAM

Ensaio a decorrerMicrovascular Damage in Sickle Cell Disease
Amsterdam UMC, locatie AMC
Afdeling Hematologie

REINO UNIDO

Greater London
LONDON

REINO UNIDO

Greater London
LONDON

Ensaio a decorrerAn open-label, multi-center clinical trial of eculizumab in pediatric patients with atypical hemolytic-uremic syndrome (aHUS) (Phase II) - UK
University College London Hospitals, NHS Foundation Trust
Renal Office - Consultant Paediatric Nephrologist

REINO UNIDO

Greater Manchester
ADDRESS: NOT PROVIDED - UK

REINO UNIDO

West Midlands
BIRMINGHAM

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

BELGICA

ANTWERPEN
ANTWERPEN-EDEGEM

ESPANHA

Cataluña
BARCELONA

ESPANHA

Cataluña
BARCELONA

ESPANHA

Comunidad Valenciana
VALENCIA

ESPANHA

Comunidad Valenciana
VALENCIA

ESPANHA

Madrid
MADRID

Ensaio a decorrerA Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia - ES
Hospital General Universitario Gregorio Marañón
Servicio de Hematología y Hemoterapia

ESPANHA

Madrid
MAJADAHONDA

Ensaio a decorrerA Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia - ES
Hospital Universitario Puerta de Hierro - Majadahonda
Servicio de Hematología y Hemoterapia

ESPANHA

Madrid
MAJADAHONDA

ITALIA

EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT

ITALIA

EMILIA ROMAGNA
FERRARA

Ensaio a decorrerAn Open-Label Extension Study to Evaluate the Long-Term Effects of ACE-536 in Patients With beta-Thalassemia Previously Enrolled in Study A536-04
A.O.U. di Ferrara - Nuovo Ospedale S.Anna - Sede di Cona
Day Hospital della Talassemia e delle Emoglobinopatie

Ensaio (s) clínico (s) multinacional (ais)

ESPANHA

Madrid
MADRID

Financiado por um membro do IRDiRCEUROFANCOLEN: Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action
CIEMAT - Centro de Investigaciones Energéticas Medioambientales y Tecnológicas
Terapias innovadoras en el sistema hematopoyético